Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02908464 · ClinicalTrials.gov registry record · NA

Prevention of Early Postoperative Decline

A NA study of Delirium and Postoperative Cognitive Dysfunction, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT02908464 is a NA study of Delirium and Postoperative Cognitive Dysfunction that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 45 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02908464, a NA study of Delirium and Postoperative Cognitive Dysfunction, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The purpose of this trial is to determine whether using a brain training program in the time leading up to as well as after heart surgery will reduce confusion and cognitive loss that can occur after surgery.

Interventions

  • DEVICE Lumosity

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2016-11
Est. Completion 2019-09
Phase NA

What the Registry Record Tells You About NCT02908464

The ClinicalTrials.gov registry entry for NCT02908464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (95% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Lumosity is the first listed.

NCT02908464 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02908464 about?

NCT02908464 is a clinical study titled "Prevention of Early Postoperative Decline". The purpose of this trial is to determine whether using a brain training program in the time leading up to as well as after heart surgery will reduce confusion and cognitive loss that can occur after surgery.

What is the current status of trial NCT02908464?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-11. Estimated completion is 2019-09.

What conditions does trial NCT02908464 study?

This clinical trial studies the following conditions: Delirium, Postoperative Cognitive Dysfunction.

What interventions are being tested in trial NCT02908464?

The interventions under investigation include: Lumosity (DEVICE).

Who is sponsoring clinical trial NCT02908464?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02908464 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.